Compounder Pallimed Solutions slapped with warning letter; U.K. wants Alexion's manufacturing costs for Soliris

> The FDA has sent a warning letter to Pallimed Solutions, a compounding pharmacy in Woburn, MA, saying that its manufacturing facilities were so unsanitary that inspectors found white filamentous material and black floaters in 9 sterile drug product lots. Letter

> Contract manufacturer Cobra Biologics says it will produce a cancer drug for clinical trials for Israeli biopharmaceutical company BioCancell. Release

> India's Lupin is looking for partners to help it develop inhalers and biosimilars in an effort by the generic drug manufacturer to move up the value chain. Story

> Tennessee-based Cumberland Pharmaceuticals will begin manufacturing and marketing Vaprisol, after acquiring the treatment for hyponatremia from Astellas Pharma US. Report

And Finally... The U.K. price watchdog NICE is asking Alexion ($ALXN) to provide manufacturing and research costs for its rare-disease drug Soliris to justify its annual price of £340,200 ($569,000). Story